Lightnews — Scholar-powered news

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 7h

To register for this event… sign up here! view.message.yale.edu?qs=4715460d6...

Disclosure Policy The policy of Yale School of Medicine's Continuing Medical Education (CME) program ensures the all its educational activities maintain balance, independence, objectivity, and scientific rigor. To achieve this:

view.message.yale.edu

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 7h

yale.cloud-cme.com/default.aspx

Yale Continuing Medical Education Continuing Education

Yale Continuing Medical Education, The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education as a provider of continuing medical education. The school off...

yale.cloud-cme.com

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · 8h

The Yale Obesity Symposium
A one-day 7 CME event
November 21 2025
NEW developments in
Obesity Treatment

Speakers including:

Lee Kaplan MD PhD
Ania Jastreboff MD PhD
John Morton MD

Register NOW! cme.edu
@Yale @YaleMed @YaleSurgery
Obesity GLP-1ra Semaglutide Tirzepatide Retatrutide GLP1

2

Reposted by Neil Floch MD FACS FASMBS DABOM

FOGOLF, FOLLOW GOLF @fogolf.bsky.social · Apr 30

I lost 160 pounds, here is a side by side comparison of my swing

https://www.fogolf.com/952118/i-lost-160-pounds-here-is-a-side-by-side-comparison-of-my-swing/

I had gastric bypass surgery in June of 2024, I had quit golf completely and sold my clubs because I thought I wouldn’t be able to play …

I lost 160 pounds, here is a side by side comparison of my swing

I had gastric bypass surgery in June of 2024, I had quit golf completely and sold my clubs because I thought I wouldn’t be able to play again. by naughtyasf143

www.fogolf.com

1 1 2

Reposted by Neil Floch MD FACS FASMBS DABOM

Nature Reviews Endocrinology @natrevendo.nature.com · Aug 12

From our September issue: Bile acids in the crosshairs for hypoglycaemia after gastric bypass, a News & Views from Marzieh Salehi (£) bit.ly/3H6tHhG #EndoSky #MedSky

Figure showing enterohepatic circulation of bile acids.

1 1 1

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Sep 4

onlinelibrary.wiley.com/doi/10.1002/...

Tirzepatide Associated With Improved Health‐Related Quality of Life in Adults With Obesity or Overweight in SURMOUNT‐4

Objective In SURMOUNT-4, participants with obesity or overweight regained substantial weight after tirzepatide withdrawal, whereas continued treatment resulted in additional weight reduction. We eva.....

onlinelibrary.wiley.com

2

Reposted by Neil Floch MD FACS FASMBS DABOM

Demetre Daskalakis @drdemetre.bsky.social · Aug 28

Enough is enough. The health of the country is in danger. Read our resignation letters: insidemedicine.substack.com/p/breaking-n...

Breaking News: Read three top CDC officials' resignation emails.

The end of an era.

insidemedicine.substack.com

280 2.4K 5.3K

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Aug 26

Revisional Bariatric Surgery in The Elderly: A Comprehensive Review of the Safety and Efficacy Profile - Surgery for Obesity and Related Diseases www.soard.org/article/S155... #SOARD #bariatricsurgery #obesity

Revisional Bariatric Surgery in The Elderly: A Comprehensive Review of the Safety and Efficacy Profile

Despite the well-known safety and efficacy of metabolic and bariatric surgery (MBS), certain patients require revisional bariatric surgery (RBS) due to weight-related and/or procedure-related complica...

www.soard.org

2 6

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Aug 12

The Impact of Bariatric Surgery on Cardiovascular Risk Factors and Outcomes: A Systematic Review | Cureus
x.com/neilflochmd/...

x.com

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Aug 12

Effect of food environment on weight loss after bariatric surgery - Surgery for Obesity and Related Diseases #SOARD #bariatricsurgery #obesity

x.com/soard_journa...

SOARD Journal on X: "Effect of food environment on weight loss after bariatric surgery - Surgery for Obesity and Related Diseases #SOARD #bariatricsurgery #obesity https://t.co/THiNjGTHAR" / X

Effect of food environment on weight loss after bariatric surgery - Surgery for Obesity and Related Diseases #SOARD #bariatricsurgery #obesity https://t.co/THiNjGTHAR

x.com

1

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Aug 12

x.com/neilflochmd/...

Neil Floch MD on X: "Effect of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: An Exploratory Metabolomics and Validation Study | Obesity Surgery https://t.co/muF9lrejTk" / X

Effect of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: An Exploratory Metabolomics and Validation Study | Obesity Surgery https://t.co/muF9lrejTk

x.com

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Jul 21

Single-anastomosis duodenal-ileal bypass with sleeve gastrectomy for diabetes: predictors of remission and metabolic outcomes in a multicenter study - Surgery for Obesity and Related Diseases www.soard.org/article/S155...

Single-anastomosis duodenal-ileal bypass with sleeve gastrectomy for diabetes: predictors of remission and metabolic outcomes in a multicenter study

The single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) combines the restrictive aspects of a sleeve gastrectomy (SG) with the hypoabsorptive advantages of a gastric bypass. SADI...

www.soard.org

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Apr 23

GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study - Surgery for Obesity and Related Diseases www.soard.org/article/S155...

GLP-1 receptor agonists and the risk of postoperative nausea and vomiting after laparoscopic sleeve gastrectomy: a single-center, retrospective cohort study

Whether preoperative exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with postoperative nausea and vomiting (PONV) after laparoscopic sleeve gastrectomy (LSG) remains ...

www.soard.org

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Apr 20

Weight stigma asa barrier to care www.medscape.com/viewarticle/...

Weight Stigma Remains a Barrier to Patient Care

Patients with obesity often report being shamed and stigmatized in medical settings. How can physicians address weight sensitively?

www.medscape.com

3

Reposted by Neil Floch MD FACS FASMBS DABOM

GoggleDocs @goggledocs.bsky.social · Mar 21

Oral semaglutide cost-effective vs. liraglutide—even at 50% ⤵️ price

🔹 🇬🇧 modelled data: ⤴️ QALYs (+0.18) & ⤵️ comp.

🔸 💊 = ⤵️ Rx burden vs. daily 💉

🔹 Results robust across sensitivity analyses

⚠️ funded by NovoNordisk

👉 Challenges low-cost liraglutide, supports 🎯 oral GLP-1 use

🔗 ggdocs.co/9h0bz1

1 1

Reposted by Neil Floch MD FACS FASMBS DABOM

GoggleDocs @goggledocs.bsky.social · Mar 22

📢 #GLP1 ⤵️ kidney decline, CV events & mortality in CKD❗️

🔹 Meta-analysis of 18K pts w/ eGFR <60:
⤵️ eGFR decline ≥50% (OR 0.72)
⤵️ 💔 (OR 0.86)
⤵️ ☠️ (OR 0.77)

🔸 ⤵️⤵️ with human GLP-1 backbone

🥇Evidence across CKD stages—not just macroalbuminuria

👉 GLP-1 now a key 🎯 in CKD + #T2D

🔗 ggdocs.co/tnqomz

1 1

Reposted by Neil Floch MD FACS FASMBS DABOM

Prof Derek Connolly @profderekconnolly.bsky.social · Mar 22

🌍 Our real-world paper shows GLP1s are associated with lower risk of MACE & less costs than DPP4s or insulin in T2DM at higher CV risk 💔

link.springer.com/article/10.1...

@pccs.bsky.social @goggledocs.bsky.social @sabouretcardio.bsky.social @astonuniversity.bsky.social @swbhnhs.bsky.social

Real-World Comparisons Between Glucagon-Like Peptide-1 Receptor Agonists and Other Glucose-Lowering Agents in Type 2 Diabetes: Retrospective Analyses of Cardiovascular and Economic Outcomes in England...

Introduction Clinical trials have demonstrated that glucagon-like peptide-1 receptor agonists (GLP-1RAs) reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes (T...

link.springer.com

2 4

Reposted by Neil Floch MD FACS FASMBS DABOM

GoggleDocs @goggledocs.bsky.social · Apr 15

📢 Danuglipron dropped—can orforglipron still be the “oral GLP-1 that delivers”?

🔹 Pfizer halts danuglipron after liver signal

🔸 Orforglipron P2=HbA1c ⤵️2.1%, Wt ⤵️14.7%, no liver signal

🔹 P3 2025—will it safely deliver?

👉 Small molecule GLP-1: blockbuster or cautionary tale?

🔗 ggdocs.co/5qu8y3

ggdocs.co

1 2

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Apr 19

Stress Eating and the Microbiome
Can you treat eating disorders with a #microbiome-friendly diet? www.psychologytoday.com/us/blog/mood...

Stress Eating and the Microbiome

Stress eating changes your gut microbes, which increases stress in a vicious cycle. By fixing your microbiome, you become more resilient, making it easier to gain back control.

www.psychologytoday.com

2

Reposted by Neil Floch MD FACS FASMBS DABOM

Scott C Anderson @scottcanderson.bsky.social · Apr 18

What a fecal microbiota transplant lacks in glamour, it totally makes up for in efficacy.
scottcanderson.substack.com/p/a-surprisi...

A Surprising Fix for a Personality-Changing Liver Disease

“Our bodies have a finely tuned, built-in detoxifying system: It's called our liver, and it can detoxify our bodies better than any cleanse or fast.” —Harley Pasternak

scottcanderson.substack.com

1 1 5

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Apr 13

www.nytimes.com/2025/03/06/w...

Are Ultraprocessed Foods Addictive?

The question has generated controversy among scientists. Here’s what we know.

www.nytimes.com

2

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Apr 12

A message from @OMAsocial past PRESIDENT and #OAC board member @DrAngelaFitch:

IT IS TIME for #GLP1 #obesity medication pharmaceutical producers to:

#betheHERO #betheHERO!

Cut the cost to $299 a month and Increase access to care!

1 3

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Apr 3

Yes people are
Success people

2

Reposted by Neil Floch MD FACS FASMBS DABOM

medscape.com @medscape.com · Mar 23

As bariatric surgery evolves to make the most of GLP-1 drugs, issues of when and how to use them for best results are a key focus: http://ms.spr.ly/63320qwot8

2 6

Reposted by Neil Floch MD FACS FASMBS DABOM

Neil Floch MD FACS FASMBS DABOM @neilflochmd.bsky.social · Mar 24

There are a lot of errors in this misleading article. For instance… reducing the size of the stomach is only one way in which bariatric surgery works - it also increases GLP-1, PYY, and other gut hormones, reduces Ghrelin, increases blood bile acids, alters the microbiome among other benefits

Robert Roy Britt @robertroybritt.bsky.social · Mar 20

The new weight loss drugs like Ozempic, Wegovy and Mounjaro are wildly popular for weight loss and are changing not just how people approach it, but what they then don't do instead, such as bariatric surgery. This doctor offers lots of important food for thought for anyone considering either.

Surgery or Meds: What’s the Best Approach to Weight Loss?

One may have better outcomes but the other can play a big role, and the decision depends on each person’s specific needs

medium.com

3 3